We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$23.4M
Cap. Flow
+$361K
Cap. Flow %
0.13%
Top 10 Hldgs %
98.06%
Holding
20
New
2
Increased
1
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
TCRT icon
Alaunos Therapeutics
TCRT
+$3.53M
2
IVZ icon
Invesco
IVZ
+$200K
3
MBLY
Mobileye N.V.
MBLY
+$185K

Top Sells

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$3.3M
2
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$130K
3
KMI icon
Kinder Morgan
KMI
+$50K
4
VOE icon
Vanguard Morningstar Mid-Cap Value ETF
VOE
+$11.8K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$11.8K

Sector Composition

Rank Sector Weight
1 Healthcare 90.02%
2 Energy 2.99%
3 Materials 0.74%
4 Technology 0.66%
5 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
1
Alaunos Therapeutics
TCRT
$4.88M
$145M 51.72%
80,419
+2,271
+3% +$3.53M
PGEN icon
2
Precigen
PGEN
$2.45B
$102M 36.62%
2,118,986
-78,402
-4% -$3.3M
WPZ
3
DELISTED
Williams Partners L.P.
WPZ
$8.37M 2.99%
172,732
– –
BPTH
4
DELISTED
Bio-Path Holdings Inc
BPTH
$4.41M 1.57%
958
– –
VOO icon
5
Vanguard S&P 500 ETF
VOO
$1.03T
$3.1M 1.11%
16,421
-61
-0.4% -$11.8K
VEA icon
6
Vanguard FTSE Developed Markets ETF
VEA
$238B
$2.58M 0.92%
65,204
-261
-0.4% -$10.8K
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.48M 0.88%
60,541
-248
-0.4% -$10.7K
VOE icon
8
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$2.38M 0.85%
26,234
-128
-0.5% -$11.8K
GMO
9
DELISTED
General Moly, Inc.
GMO
$2.07M 0.74%
2,922,831
– –
VDE icon
10
Vanguard Energy ETF
VDE
$10.4B
$1.82M 0.65%
17,039
-70
-0.4% -$7.87K
GLD icon
11
SPDR Gold Trust
GLD
$144B
$1.73M 0.62%
15,361
-61
-0.4% -$6.98K
TXN icon
12
Texas Instruments
TXN
$253B
$1.65M 0.59%
32,000
– –
VNQ icon
13
Vanguard Real Estate ETF
VNQ
$38.6B
$1.38M 0.49%
18,431
-72
-0.4% -$5.75K
LXRX icon
14
Lexicon Pharmaceuticals
LXRX
$1.05B
$287K 0.1%
35,714
– –
MBLY
15
DELISTED
Mobileye N.V.
MBLY
$207K 0.07%
+3,900
New +$185K
IVZ icon
16
Invesco
IVZ
$13.9B
$187K 0.07%
+5,000
New +$200K
POR icon
17
Portland General Electric
POR
$5.74B
$4K ﹤0.01%
118
– –
EFX icon
18
Equifax
EFX
$21.2B
$3K ﹤0.01%
29
– –
KMI icon
19
Kinder Morgan
KMI
$70.7B
– –
-1,200
Closed -$50K
VTAE
20
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-11,100
Closed -$130K

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2015 Portfolio in Review

As of Q2 2015, University of Texas/Texas AM Investment Management Co (UTIMCO) held 20 positions worth $280M, up 9.1% from $256M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2015 filing shows 2 new, 1 increased, 8 reduced and 2 closed positions. Its largest new stake was Invesco: 5,000 shares worth $187K. The largest sale was Precigen, an estimated $3.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Energy and Materials.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q2 2015 buy was Invesco: 5,000 shares worth $187K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Alaunos Therapeutics in Q2 2015, an estimated $3.53M increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q2 2015 reduction was Precigen, cutting an estimated $3.3M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015, selling an estimated $130K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 98% of its $280M portfolio in Q2 2015.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 2 new positions and closed 2 in Q2 2015.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 9.1% quarter-over-quarter to $280M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2015, filed 13 Aug 2015.